Clinical Trials Browser

Camurati-Engelmann Syndrome × Cyclophosphamide × 1 year × Clear all

NCT02065362 2026-01-29

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC

Phase 1 Active not recruiting

Nasopharyngeal Carcinoma, Camurati-Engelmann Syndrome